---

Referenser

1. Drossman, D.A. and W.L. Hasler, Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 2016. 150(6): p. 1257-61.

2. Sperber, A.D., S.I. Bangdiwala, D.A. Drossman, U.C. Ghoshal, M. Simren, J. Tack, el al.

3. Mearin, F., B.E. Lacy, L. Chang, W.D. Chey, A.J. Lembo, M. Simren, et al, Bowel Disorders. Gastroenterology, 2016:150(6);p1393-1407.e5.

4. Black, C.J., D.A. Drossman, N.J. Talley, J. Ruddy, and A.C. Ford, Functional gastrointestinal disorders: advances in understanding and management. Lancet, 2020. 396(10263): p. 1664-1674.

5. Chang, J.Y., G.R. Locke, 3rd, M.A. McNally, S.L. Halder, C.D. Schleck, A.R. Zinsmeister, et al, Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol, 2010. 105(4): p. 822-32.

6. Tornkvist, N.T., M. Simren, J.P. Hreinsson, J. Tack, S.I. Bangdiwala, A.D. Sperber, et al. Prevalence and impact of disorders of Gut-Brain interaction in Sweden. Neurogastroenterol Motil, 2023. 35(6): p. e14578.

7. Ohlsson, B., Extraintestinal manifestations in irritable bowel syndrome: A systematic review. Therap Adv Gastroenterol, 2022. 15: p. 17562848221114558.

8. Simren, M., H. Tornblom, O.S. Palsson, L. Van Oudenhove, W.E. Whitehead, and J. Tack, Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology, 2019. 157(2): p. 391-402 e2.

9. Borup, C., L. Vinter-Jensen, S.P.G. Jorgensen, S. Wildt, J. Graff, T. Gregersen, et al. Prospective comparison of diagnostic tests for bile acid diarrhoea. Aliment Pharmacol Ther, 2024. 59(1): p. 39-50.

10. Balsiger, L.M., F. Carbone, K. Raymenants, E. Scarpellini, and J. Tack, Understanding and managing patients with overlapping disorders of gut-brain interaction. Lancet Gastroenterol Hepatol, 2023. 8(4): p. 383-390.

11. Nunan, D., T. Cai, A.D. Gardener, J.M. Ordonez-Mena, N.W. Roberts, E.T. Thomas, et al. Physical activity for treatment of irritable bowel syndrome. Cochrane Database Syst Rev, 2022. 6(6): p. CD011497.

12. National Institute for Health and Care Excellence - Irritable bowel syndrome in adults: diagnosis and management. 2008.

13. Lindfors, P., E. Axelsson, K. Engstrand, S. Storsrud, P. Jerlstad, H. Tornblom, et al. Online Education Is Non-Inferior to Group Education for Irritable Bowel Syndrome: A Randomized Trial and Patient Preference Trial. Clin Gastroenterol Hepatol, 2021. 19(4): p. 743-751 e1.

14. Didari, T., S. Mozaffari, S. Nikfar, and M. Abdollahi, Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol, 2015. 21(10): p. 3072-84.

15. Black, C.J., H.M. Staudacher, and A.C. Ford, Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 2022. 71(6): p. 1117-1126.

16. Black, C.J., E.R. Thakur, L.A. Houghton, E.M.M. Quigley, P. Moayyedi, and A.C. Ford, Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut, 2020. 69(8): p. 1441-1451.

17. Peters, S.L., P.R. Gibson, and E.P. Halmos, Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation. Neurogastroenterol Motil, 2023. 35(4): p. e14533.

18. Vanuytsel, T., J.F. Tack, and G.E. Boeckxstaens, Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol, 2014. 49(8): p. 1193-205.

19. Lembo, A.J., H.A. Schneier, S.J. Shiff, C.B. Kurtz, J.E. MacDougall, X.D. Jia, J.Z. et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med, 2011. 365(6): p. 527-36.

20. Camilleri, M., R. Kerstens, A. Rykx, and L. Vandeplassche, A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med, 2008. 358(22): p. 2344-54.

21. Muhlenbrock, C.V., P. Nunez, R. Quera, and A.M. Madrid, Narcotic Bowel Syndrome, an Under-recognized Cause of Chronic Abdominal Pain in Adults. J Neurogastroenterol Motil, 2022. 28(4): p. 706-708.

22. Nee, J., S. Ballou, J.M. Kelley, T.J. Kaptchuk, W. Hirsch, J. Katon, et al. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol, 2021. 116(11): p. 2279-2285.

23. Black, C.J., Y. Yuan, C.P. Selinger, M. Camilleri, E.M.M. Quigley, P. Moayyedi, et al. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol, 2020. 5(2): p. 117-131.

24. Ford, A.C., A. Wright-Hughes, S.L. Alderson, P.L. Ow, M.J. Ridd, R. Foy, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 2023. 402(10414): p. 1773-1785.

25. Kulak-Bejda, A., G. Bejda, and N. Waszkiewicz, Antidepressants for irritable bowel syndrome-A systematic review. Pharmacol Rep, 2017. 69(6): p. 1366-1379.

26. Chang, L., S. Sultan, A. Lembo, G.N. Verne, W. Smalley, and J.J. Heidelbaugh, AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology, 2022. 163(1): p. 118-136.

27. Cann, P.A., N.W. Read, C.D. Holdsworth, and D. Barends, Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci, 1984. 29(3): p. 239-47.

28. Min, Y.W., A. Rezaie, and M. Pimentel, Bile Acid and Gut Microbiota in Irritable Bowel Syndrome. J Neurogastroenterol Motil, 2022. 28(4): p. 549-561.

29. Camilleri, M. and P. Vijayvargiya, The Role of Bile Acids in Chronic Diarrhea. Am J Gastroenterol, 2020. 115(10): p. 1596-1603.

30. Savarino, E., F. Zingone, B. Barberio, G. Marasco, F. Akyuz, H. Akpinar, et al. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterol J, 2022. 10(6): p. 556-584.